Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market

Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market...but the oral and injectable forms will stay.

Trimethobenzamide was one of those "unapproved" drugs that came on the market before proof of efficacy was required. Now the FDA is requiring efficacy data...or they will take these drugs off the market.

There's just not enough evidence the suppositories are effective.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote